Air Water Inc (AWI) is a manufacturer and marketer of industrial gases, chemicals, medical, energy, agricultural and food products. It carries out its business operations through subsidiaries and affiliated companies.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

AWI is actively engaged in research and development across various sectors to drive innovation and address societal challenges. The company is focusing on developing new materials for digital and industrial applications, enhancing energy solutions for a decarbonized society, advancing medical technologies, and improving agricultural and food security. AWI have plans including the development of high-performance electronic materials, CO2 capture and utilization technologies, ultra-thin endoscopes, and smart agriculture systems. The company is also working on enhancing the quality and preservation of food products and exploring new business opportunities through the utilization of seawater resources. The company's R&D activities are managed by several units, including the Technology Strategy Department, Intellectual Property Strategy Department, and Gas Technology Development Center, all established under the direct supervision of the President. These units are responsible for accelerating technology and product development, managing intellectual property, and advancing gas-related technologies. Additionally, the "Air Water Forest" and "Shonan Innovation Lab" serve as key research centers for open innovation and the development of semiconductors, battery, and functional materials. In FY2025, the company incurred expenses of JPY4,991 million on R&D, which as a percentage of revenue stood at 0.5%.